Hematology/Oncology Education and CME

Select a Specialty

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker
CMEABIM MOC

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker

There is no commercial support for this activity.

Expiration Date: 8/14/2020
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will utilize a case study to discuss the management of small cell lung cancer in a 67-year-old male….

go to activity»
Ace the Case: A 44-Year-Old Man With a History of Melanoma and a New Onset of Brain Metastases
CMEABIM MOC

Ace the Case: A 44-Year-Old Man With a History of Melanoma and a New Onset of Brain Metastases

There is no commercial support for this activity.

Expiration Date: 7/14/2020
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will utilize a case study to discuss the management of a 44-year-old man with brain metastases….

go to activity»
Evolving role of stem cell transplant in older AML patients

Evolving Role of Stem Transplant in Older AML Patients

Supported by Actinium Pharmaceuticals Inc.

July 8, 2019

Watch as four experts discuss the evolving role of stem cell transplant in older patients with acute myeloid leukemia….

go to activity»
2019 Texas Oncology Clinical Educational Symposium
CME

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

Expiration Date: 6/27/2020
Credit Type(s): CME | Credit: 2.5

Clinical outcomes for advanced cancers continue to improve through the identification as well as the development of novel diagnostic and therapeutic approaches that are…

go to activity»
Ace the Case: A 54-year-old Man With 2 Weeks of Progressive Shortness of Breath
CMEABIM MOC

Ace the Case: A 54-year-old Man With 2 Weeks of Progressive Shortness of Breath

There is no commercial support for this activity.

Expiration Date: 6/16/2020
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will utilize a case study to discuss the management of a 54-year-old man with 2 weeks of progressive shortness of breath and pancytopenia….

go to activity»
Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago
CME

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 6/10/2020
Credit Type(s): CME | Credit: 1

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly diagnosed late in the course of the disease. Several new therapies have been recently approved by…

go to activity»
CLL Awareness

The introduction of targeted therapy has transformed the landscape of treatment for chronic lymphocytic leukemia….

go to activity»
Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board
CME

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 7/7/2020
Credit Type(s): CME | Credit: 1

The treatment paradigm for the management of patients with advanced cancer has changed dramatically within recent years due to the discovery, clinical evaluation, and…

go to activity»
Metastatic Breast Cancer Video Perspectives

Jame Abraham, MD, director of the breast oncology program at Cleveland Clinic, spoke with Healio about recent advances in the management of metastatic breast cancer….

go to activity»
Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision Making – Rapid Response From Amsterdam
CME

Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision-making – Rapid Response From Amsterdam

This activity is supported by an educational grant from Global Blood Therapeutics.

Expiration Date: 6/24/2020
Credit Type(s): CME | Credit: 0.75

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic variability among individuals. Even though SCD is a…

go to activity»
Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago
CME

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

This activity is supported by an educational grant from Biotheranostics, Inc.

Expiration Date: 6/10/2020
Credit Type(s): CME | Credit: 1

Multigene assays that evaluate an array of prognostic and/or predictive molecular markers have become critical for the optimal management of patients with breast cancer…

go to activity»
Clinical Evidence and Management Strategies in BRAF + Stage III and Metastatic Melanoma

Clinical Evidence and Management Strategies in BRAF+ Stage III and Metastatic Melanoma

This activity is sponsored by Novartis Pharmaceuticals Corporation.

June 12, 2018

Discover key efficacy and safety data as well as patient case studies for a therapy for patients with BRAF+ stage III or metastatic melanoma….

go to activity»